WO2001094598A3 - Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires - Google Patents

Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires Download PDF

Info

Publication number
WO2001094598A3
WO2001094598A3 PCT/IB2001/000996 IB0100996W WO0194598A3 WO 2001094598 A3 WO2001094598 A3 WO 2001094598A3 IB 0100996 W IB0100996 W IB 0100996W WO 0194598 A3 WO0194598 A3 WO 0194598A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid construct
stem cells
embryonic stem
sequence
Prior art date
Application number
PCT/IB2001/000996
Other languages
English (en)
Other versions
WO2001094598A2 (fr
Inventor
Ludovic Vallier
Jimmy Mancip
Daniel Metzger
Pierre Chambon
Jacques Samarut
Pierre Savatier
Original Assignee
Centre Nat Rech Scient
Agronomique Inst Nat Rech
Ecole Norm Superieure Lyon
Inst Nat Sante Rech Med
Ludovic Vallier
Jimmy Mancip
Daniel Metzger
Pierre Chambon
Jacques Samarut
Pierre Savatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Agronomique Inst Nat Rech, Ecole Norm Superieure Lyon, Inst Nat Sante Rech Med, Ludovic Vallier, Jimmy Mancip, Daniel Metzger, Pierre Chambon, Jacques Samarut, Pierre Savatier filed Critical Centre Nat Rech Scient
Priority to EP01934255A priority Critical patent/EP1294917A2/fr
Priority to JP2002502139A priority patent/JP2004500865A/ja
Priority to US10/297,475 priority patent/US20040053361A1/en
Publication of WO2001094598A2 publication Critical patent/WO2001094598A2/fr
Publication of WO2001094598A3 publication Critical patent/WO2001094598A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • C12N2840/206—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cette invention concerne une construction d'acide nucléique exempte de promoteur, comprenant une séquence de sélection et une séquence codant pour une protéine d'intérêt distincte de la séquence de sélection, ladite séquence codante étant précédée en amont par une séquence permettant sa traduction par les ribosomes, ainsi que les utilisations de cette construction dans les domaines de la biologie et de la médecine.
PCT/IB2001/000996 2000-06-07 2001-06-07 Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires WO2001094598A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01934255A EP1294917A2 (fr) 2000-06-07 2001-06-07 Constructions d'acide nucleique utiles pour l'expression de transgenes notamment dans les cellules souches embryonnaires
JP2002502139A JP2004500865A (ja) 2000-06-07 2001-06-07 特に胚性幹細胞において導入遺伝子を発現するために有用な核酸コンストラクト
US10/297,475 US20040053361A1 (en) 2000-06-07 2001-06-07 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/07298 2000-06-07
FR0007298A FR2810048A1 (fr) 2000-06-07 2000-06-07 Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires

Publications (2)

Publication Number Publication Date
WO2001094598A2 WO2001094598A2 (fr) 2001-12-13
WO2001094598A3 true WO2001094598A3 (fr) 2002-05-30

Family

ID=8851052

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/000996 WO2001094598A2 (fr) 2000-06-07 2001-06-07 Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires

Country Status (5)

Country Link
US (1) US20040053361A1 (fr)
EP (1) EP1294917A2 (fr)
JP (1) JP2004500865A (fr)
FR (1) FR2810048A1 (fr)
WO (1) WO2001094598A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216203D0 (en) * 2002-07-12 2002-08-21 Imp Cancer Res Tech Mondulation of cytochrome P450 reductase activity
WO2016196666A2 (fr) * 2015-06-01 2016-12-08 Bloodworks Souris dotées de la glucose-6-phosphate déshydrogénase modifiée (g6pd) et utilisations associées
EA202090585A1 (ru) * 2017-09-19 2020-07-08 Дзе Стэйт Оф Исраэль, Министри Оф Эгрикалчур Энд Рурал Девелопмент, Эгрикалчурал Ресерч Организэйшн (Аро) (Волкани Сентер) Птицы с отредактированным геномом

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014809A2 (fr) * 1995-10-16 1997-04-24 Dana-Farber Cancer Institute Nouveaux vecteurs d'expression et procedes d'utilisation correspondants
WO1998014614A1 (fr) * 1996-10-04 1998-04-09 Lexicon Genetics Incorporated Banque indexee de cellules contenant des modifications genomiques et son procede d'elaboration et d'utilisation
WO1998024818A1 (fr) * 1996-12-02 1998-06-11 Astra Pharma Inc. Nouveau recepteur de trh
WO1999002719A1 (fr) * 1997-07-11 1999-01-21 The University Of British Columbia Piege de complementation
US5922601A (en) * 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
WO1999053017A2 (fr) * 1998-04-15 1999-10-21 Fred Hutchinson Cancer Research Center Procedes et constructions vecteurs pour produire des animaux transgeniques exprimant de maniere ubiquiste un gene heterologue
WO2000024881A1 (fr) * 1998-10-26 2000-05-04 The Regents Of The University Of California Vecteurs de piegeage de genes

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922601A (en) * 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
WO1997014809A2 (fr) * 1995-10-16 1997-04-24 Dana-Farber Cancer Institute Nouveaux vecteurs d'expression et procedes d'utilisation correspondants
WO1998014614A1 (fr) * 1996-10-04 1998-04-09 Lexicon Genetics Incorporated Banque indexee de cellules contenant des modifications genomiques et son procede d'elaboration et d'utilisation
WO1998024818A1 (fr) * 1996-12-02 1998-06-11 Astra Pharma Inc. Nouveau recepteur de trh
WO1999002719A1 (fr) * 1997-07-11 1999-01-21 The University Of British Columbia Piege de complementation
WO1999053017A2 (fr) * 1998-04-15 1999-10-21 Fred Hutchinson Cancer Research Center Procedes et constructions vecteurs pour produire des animaux transgeniques exprimant de maniere ubiquiste un gene heterologue
WO2000024881A1 (fr) * 1998-10-26 2000-05-04 The Regents Of The University Of California Vecteurs de piegeage de genes

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ARAKI K ET AL: "EXCHANGEABLE GENE TRAP USING THE CRE/MUTATED LOX SYSTEM", MOLECULAR AND CELLULAR BIOLOGY,US,AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, vol. 45, no. 5, July 1999 (1999-07-01), pages 737 - 750, XP000877476, ISSN: 0270-7306 *
B P ZAMBROWICZ AND G A FRIEDRICH: "Comprehensive mammalian genetics: history and fututre prospects of gene trapping in the mouse", INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY,UNIVERSITY OF THE BASQUE COUNTRY PRES, LEIOA,ES, vol. 42, 1998, pages 1025 - 1036, XP002111634, ISSN: 0214-6282 *
BÖGER H AND GRUSS P: "Functional determinants for the tetracycline-dependent transactivator tTA in transgenic mouse embryos", MECH DEV, vol. 83, no. 1-2, May 1999 (1999-05-01), pages 141 - 153, XP002927503 *
DANIELIAN P ET AL: "Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase", CURR BIOL, vol. 8, no. 24, 3 December 1998 (1998-12-03), pages 1323 - 1326, XP000993084 *
GORSKI JESSICA A ET AL: "Efficient bicistronic expression of cre in mammalian cells", NUCLEIC ACIDS RESEARCH,OXFORD UNIVERSITY PRESS, SURREY,GB, vol. 27, no. 9, 1 May 1999 (1999-05-01), pages 2059 - 2061, XP002154798, ISSN: 0305-1048 *
INDRA A ET AL: "Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases", NUCLEIC ACIDS RESEARCH., vol. 27, no. 22, 15 November 1999 (1999-11-15), pages 4324 - 4327, XP002165979 *
RUSS A ET AL: "Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 93, no. 26, 24 December 1996 (1996-12-24), pages 15279 - 15284, XP002165981 *
SOKOLIC R A ET AL: "A BICISTRONIC RETROVIRUS VECTOR CONTAINING A PICORNAVIRUS INTERNAL RIBOSOME ENTRY SITE ALLOWS FOR CORRECTION OF X-LINKED CGD BY SELECTION FOR MDR1 EXPRESSION", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 87, no. 1, 1996, pages 42 - 50, XP002058840, ISSN: 0006-4971 *
STAAL F J T ET AL: "USE OF BICISTRONIC RETROVIRAL VECTORS ENCODING THE LACZ GENE TOGETHER WITH A GENE OF INTEREST: A METHOD TO SELECT PRODUCER CELLSAND FOLLOW TRANSDUCED TARGET CELLS", CANCER GENE THERAPY, NORWALK, CT, US, vol. 3, no. 5, 1 September 1996 (1996-09-01), pages 345 - 351, XP002058839, ISSN: 0929-1903 *
THOREY I ET AL: "Selective disruption of genes transiently induced in differentiating mouse embryonic stem cells by using gene trap mutagenesis and site-specific recombination", MOL CELL BIOL, vol. 18, no. 5, May 1998 (1998-05-01), pages 3081 - 3088, XP002165980 *
VALLIER L ET AL: "An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 98, no. 5, 27 February 2001 (2001-02-27), pages 2467 - 2472, XP002165982 *

Also Published As

Publication number Publication date
US20040053361A1 (en) 2004-03-18
EP1294917A2 (fr) 2003-03-26
FR2810048A1 (fr) 2001-12-14
WO2001094598A2 (fr) 2001-12-13
JP2004500865A (ja) 2004-01-15

Similar Documents

Publication Publication Date Title
WO2006083276A3 (fr) Polypeptides et conjugues interferon-alpha
WO2005113592A3 (fr) Polypeptides et conjugues interferon-alpha
AU2001241406A1 (en) Nucleic acids, proteins, and antibodies
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
WO2004046365A3 (fr) Polypeptides et conjugues interferon-alpha
WO2002014485A3 (fr) Nouveau gene kallikreine
WO2003040681A3 (fr) Genes codant des proteines de la voie metabolique
WO2006127822A3 (fr) Polypeptides associes au domaine 1 de scytovirine
AU2002214542A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2001094598A3 (fr) Construction d'acide nucleique utile pour l'expression de transgenes notamment dans les cellules souches embryonnaires
WO2006035311A3 (fr) Proteine crge de streptococcus de groupe a
WO2001066752A3 (fr) Genes specifiques de la reproduction
WO2002048187A3 (fr) Peptides du signal de secretion, leurs sequences adn, vecteurs d'expression pour cellules eucaryotes preparees a partir de ceux-ci, et leur utilisation pour la preparation biotechnologique de proteines
AU2001288363A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2003031642A3 (fr) Molecules regulatrices de variant love
AU2002229060A1 (en) Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
WO2003040293A3 (fr) Genes codant des proteines de resistance et de tolerance au stress
WO2002022822A3 (fr) Homologues de bag provenant de plantes
AU2001229508A1 (en) Nucleic acids, proteins, and antibodies
WO2003040357A3 (fr) Genes codant des proteines phosphoenolpyruvate-sucre phototransferase
WO2001005957A3 (fr) Proteines virales associees a l'enroulement de la vigne
WO2002006309A3 (fr) Peptides signaux d'exportation nucleaire (nes), proteines de fusion qui les contiennent, ainsi que leur utilisation
AU2001241404A1 (en) Nucleic acids, proteins and antibodies
AU2001237948A1 (en) Nucleic acids, proteins, and antibodies
AU2001236459A1 (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001934255

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10297475

Country of ref document: US

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 502139

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2001934255

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001934255

Country of ref document: EP